Back to Search
JEFFREY BOOS, M.D.
M.D.
Dermatology Physician
NPI: 1477744266IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
M8546(TX)
CMS Specialties
PrimaryDERMATOLOGY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2004
Research & Publications (20)
Level of activity in children undergoing cancer treatment.
PMID 19415742·Pediatr Blood Cancer·2009
8-other
Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
PMID 18482216·Pediatr Transplant·2009
8-other
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
PMID 18286501·Pediatr Blood Cancer·2008
3-trial
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.
PMID 18580955·Leukemia·2008
3-trial
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
PMID 17457342·Pharmacogenomics J·2008
8-other
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
PMID 18285545·Blood·2008
2-rct
Modelling the spatial distribution of five natural hazards in the context of the WHO/EMRO Atlas of Disaster Risk as a step towards the reduction of the health impact related to disasters.
PMID 17343733·Int J Health Geogr·2007
8-other
Implementing Good Clinical Practice in two noncommercial phase II studies in children with cancer.
PMID 17264522·Onkologie·2007
6-review
Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases.
PMID 17907592·Int J Clin Pharmacol Ther·2007
3-trial
Comment on "determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation" by F.K. Glowka et al. [J. Chromatogr. B 850 (2007) 569-574].
PMID 17448736·J Chromatogr B Analyt Technol Biomed Life Sci·2007
8-other
Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan.
PMID 17470868·J Clin Oncol·2007
4-observational
Flat-fixed dosing versus body surface area based dosing of anticancer drugs: there is a difference.
PMID 17766651·Oncologist·2007
8-other
Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometry.
PMID 16725388·J Chromatogr B Analyt Technol Biomed Life Sci·2006
8-other
[Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law].
PMID 16763801·Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz·2006
8-other
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
PMID 16876216·Toxicol Appl Pharmacol·2006
7-preclinical
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
PMID 16917211·Anticancer Drugs·2006
8-other
Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin.
PMID 16926636·Anticancer Drugs·2006
3-trial
In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
PMID 17001175·Anticancer Drugs·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12221 N MOPAC EXPY
AUSTIN, TX 78758 - Phone
- (512) 901-4004
Quick Facts
- NPI
- 1477744266
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile